Search research articles
Contact Us
Filters
Showing results (1-10 of 56) with videos related to
Page
of 6
Sort By:
Journal of Neurochemistry
|
December 20, 2007
The GSK3 hypothesis of Alzheimer's disease
Claudie Hooper, Richard Killick, Simon Lovestone
Biological Psychiatry
|
April 4, 2015
Reducing β-amyloid by inhibition of BACE1: how low should you go?
Richard Killick, John Hardy, J Paul Simons
Virus Research
|
September 28, 2020
Transcription-based drug repurposing for COVID-19
Richard Killick, Clive Ballard, Patrick Doherty, et al.
Neuroscience Letters
|
September 10, 2010
β-Amyloid precursor protein and tau protein levels are differently regulated in human cerebellum compared to brain regions vulnerable to Alzheimer's type neurodegeneration
Mirsada Caušević, Umbreen Farooq, Simon Lovestone, et al.
Trends in Neurosciences
|
February 28, 2007
Schizophrenia as a GSK-3 dysregulation disorder
Simon Lovestone, Richard Killick, Marta Di Forti, et al.
Neuroscience Letters
|
February 16, 2007
The Notch-1 intracellular domain is found in sub-nuclear bodies in SH-SY5Y neuroblastomas and in primary cortical neurons
Claudie Hooper, J Paul Chapple, Simon Lovestone, et al.
Neuroscience Letters
|
April 4, 2006
TAp73alpha induces tau phosphorylation in HEK293a cells via a transcription-dependent mechanism
Claudie Hooper, Richard Killick, Mahvash Tavassoli, et al.
Free Radical Biology & Medicine
|
October 22, 2022
NRF2: An emerging role in neural stem cell regulation and neurogenesis
Emily Boorman, Richard Killick, Dag Aarsland, et al.
Acta Oto-Laryngologica
|
April 19, 2003
Toward an understanding of cochlear homeostasis: the impact of location and the role of OCP1 and OCP2
Ruediger Thalmann, Michael T Henzl, Richard Killick, et al.
Neuroscience Letters
|
April 3, 2007
p53 is upregulated in Alzheimer's disease and induces tau phosphorylation in HEK293a cells
Claudie Hooper, Eirini Meimaridou, Mahvash Tavassoli, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 56) with videos related to
Sort By:
Page
of 6
Journal of Neurochemistry
|
December 20, 2007
The GSK3 hypothesis of Alzheimer's disease
Claudie Hooper, Richard Killick, Simon Lovestone
Biological Psychiatry
|
April 4, 2015
Reducing β-amyloid by inhibition of BACE1: how low should you go?
Richard Killick, John Hardy, J Paul Simons
Virus Research
|
September 28, 2020
Transcription-based drug repurposing for COVID-19
Richard Killick, Clive Ballard, Patrick Doherty, et al.
Neuroscience Letters
|
September 10, 2010
β-Amyloid precursor protein and tau protein levels are differently regulated in human cerebellum compared to brain regions vulnerable to Alzheimer's type neurodegeneration
Mirsada Caušević, Umbreen Farooq, Simon Lovestone, et al.
Trends in Neurosciences
|
February 28, 2007
Schizophrenia as a GSK-3 dysregulation disorder
Simon Lovestone, Richard Killick, Marta Di Forti, et al.
Neuroscience Letters
|
February 16, 2007
The Notch-1 intracellular domain is found in sub-nuclear bodies in SH-SY5Y neuroblastomas and in primary cortical neurons
Claudie Hooper, J Paul Chapple, Simon Lovestone, et al.
Neuroscience Letters
|
April 4, 2006
TAp73alpha induces tau phosphorylation in HEK293a cells via a transcription-dependent mechanism
Claudie Hooper, Richard Killick, Mahvash Tavassoli, et al.
Free Radical Biology & Medicine
|
October 22, 2022
NRF2: An emerging role in neural stem cell regulation and neurogenesis
Emily Boorman, Richard Killick, Dag Aarsland, et al.
Acta Oto-Laryngologica
|
April 19, 2003
Toward an understanding of cochlear homeostasis: the impact of location and the role of OCP1 and OCP2
Ruediger Thalmann, Michael T Henzl, Richard Killick, et al.
Neuroscience Letters
|
April 3, 2007
p53 is upregulated in Alzheimer's disease and induces tau phosphorylation in HEK293a cells
Claudie Hooper, Eirini Meimaridou, Mahvash Tavassoli, et al.
Page
of 6